The urea breath test is a non-invasive diagnostic method used to detect the presence of Helicobacter pylori (H. pylori) bacteria in the stomach and duodenum. It involves ingesting urea labelled with carbon-13 isotope and measuring the amount of carbon dioxide in exhaled breath. H. pylori infection is the leading cause of peptic ulcers and stomach cancer. With rising incidence of H. pylori infection due to poor sanitation and hygiene in developing nations, the demand for urea breath testing is increasing significantly. The global urea breath test market offers reliable diagnosis of H. pylori infection in a cost-effective manner as compared to endoscopy or biopsy.
The global Urea Breath Test Market is estimated to be valued at US$ 140.8 Mn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends in the urea breath test market is the introduction of portable and handheld devices. Manufacturers are developing portable breath testing systems that can easily be carried to the point of care for convenient diagnosis. For instance, Exalenz Bioscience launched the LactoFrida breath testing platform in 2019, which is a portable device used to detect H. pylori infection through a non-invasive urea breath test. Such portable devices are gaining popularity as they facilitate testing at physician offices or patient bedside without needing specialized laboratory facilities. Additionally, research on developing innovative isotopes like carbon-14 for improved detection sensitivity can further augment the demand for urea breath testing over the forecast period.
Threat of new entrants: Low, as the market requires high investments for R&D and manufacturing set-up.
Bargaining power of buyers: Moderate, as there are substitute diagnosis tests available.
Bargaining power of suppliers: Moderate, as raw materials are available and key players have integrated supply chain.
Threat of new substitutes: Moderate, as new non-invasive diagnosis tests can penetrate the market.
Competitive rivalry: High, as key players focus on new product launches and geographical expansion.
The Global Urea Breath Test Market Size is expected to witness high growth. The global Urea Breath Test Market is estimated to be valued at US$ 140.8 Mn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2024 to 2031.
Europe has the highest adoption of UBT, led by the availability of advanced healthcare facilities and awareness regarding early disease diagnosis. However, Asia Pacific is expected to grow at fastest pace during the forecast period due to improving healthcare infrastructure and increasing healthcare expenditure.
Key players – Key players operating in the Urea Breath Test Market are Al Dahra ACX Global Inc., Alfalfa Monegros SL, Anderson Hay & Grain Inc., Bailey Farms, Border Valley, Coaba, Cubeit Hay Company, Glenvar Hay, Green Prairie International, Grupo OsÃ©s, Gruppo Carli, Hay USA, Haykingdom Inc., Oregon Hay Products, Inc., Los Venteros SC, M&C Hay, Legal Alfalfa Products Ltd., Riverina (Australia) Pty Ltd, SL Follen Company, and Standlee Hay Company. These major players are focusing on new product launches and partnerships to gain higher market share.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it